Literature DB >> 30251596

Comparisons of the BRIEF parental report and neuropsychological clinical tests of executive function in Fetal Alcohol Spectrum Disorders: data from the UK national specialist clinic.

Zameer Mohamed1, Alexandra C S Carlisle1, Alexandra C Livesey1, Raja A S Mukherjee1.   

Abstract

Extant literature is sparse with regards to the relationship between caregiver reports and neuropsychological tests of executive functioning in Fetal Alcohol Spectrum Disorders (FASD). The goal of this paper was determining the clinical utilities of executive functioning measures used in the United Kingdom national FASD clinic. We examined relationships between outcomes on the Behavior Rating Inventory of Executive Function (BRIEF) and the Delis-Kaplan Executive Function System (D-KEFS), as part of an ongoing service evaluation. Profiles of executive functioning measures were reported in order to contribute to delineating a profile of executive dysfunction in FASD. Caregivers of 49 people with FASD completed the Parent BRIEF, and 61 people with FASD were administered the D-KEFS. Pearson's Correlations between all 11 BRIEF scales and the 18 selected D-KEFS subscales showed little relationship. The BRIEF showed a profile of clinically significant elevations in all three Index scores and seven out of the eight Scale scores. Several D-KEFS tests showed below average executive functioning. Both executive function measures have separate clinical utility in demonstrating executive function deficits in FASD. The sample population used in this study also show a similar pattern to FASD populations internationally, suggesting a similar neuropsychological profile is seen in the United Kingdom. However, caregiver reports display little relationship to neuropsychological tests. These measures likely monitor different aspects of executive functioning in different settings. Future research should focus on identifying tests that better relate findings from clinical settings to behavior in daily life.

Entities:  

Keywords:  Behavior Rating Inventory of Executive Function (BRIEF); Delis-Kaplan Executive Function System (D-KEFS); Fetal Alcohol Spectrum Disorders (FASD); executive function; neuropsychology

Mesh:

Year:  2018        PMID: 30251596     DOI: 10.1080/09297049.2018.1516202

Source DB:  PubMed          Journal:  Child Neuropsychol        ISSN: 0929-7049            Impact factor:   2.500


  5 in total

1.  Relationship Between Task-Based and Parent Report-Based Measures of Attention and Executive Function in Children with Fetal Alcohol Spectrum Disorders (FASD).

Authors:  Julia T Mattson; John C Thorne; Sara T Kover
Journal:  J Pediatr Neuropsychol       Date:  2020-06-30

2.  School-aged children diagnosed with an FASD exhibit visuo-cortical network disturbance: A magnetoencephalography (MEG) study.

Authors:  Zinia Pervin; John F L Pinner; Lucinda Flynn; Cassandra M Cerros; Mareth E Williams; Dina E Hill; Julia M Stephen
Journal:  Alcohol       Date:  2021-12-13       Impact factor: 2.558

3.  Evaluating the Feasibility of The NIH Toolbox Cognition Battery for Autistic Children and Adolescents.

Authors:  Desiree R Jones; Aaron Dallman; Clare Harrop; Allison Whitten; Jill Pritchett; Luc Lecavalier; James W Bodfish; Brian A Boyd
Journal:  J Autism Dev Disord       Date:  2021-03-24

4.  Validity and Reliability of Executive Function Measures in Children With Heavy Prenatal Alcohol Exposure: Correspondence Between Multiple Raters and Laboratory Measures.

Authors:  Gemma A Bernes; Miguel Villodas; Claire D Coles; Julie A Kable; Philip A May; Wendy O Kalberg; Elizabeth R Sowell; Kenneth L Jones; Edward P Riley; Sarah N Mattson
Journal:  Alcohol Clin Exp Res       Date:  2021-02-15       Impact factor: 3.455

5.  Characterizing Alcohol-Related Neurodevelopmental Disorder: Prenatal Alcohol Exposure and the Spectrum of Outcomes.

Authors:  Claire D Coles; Wendy Kalberg; Julie A Kable; Barbara Tabachnick; Philip A May; Christina D Chambers
Journal:  Alcohol Clin Exp Res       Date:  2020-05-20       Impact factor: 3.928

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.